Literature DB >> 10473558

The role of individual SH2 domains in mediating association of phospholipase C-gamma1 with the activated EGF receptor.

A Chattopadhyay1, M Vecchi, Q s Ji, R Mernaugh, G Carpenter.   

Abstract

The two SH2 (Src homology domain 2) domains present in phospholipase C-gamma1 (PLC-gamma1) were assayed for their capacities to recognize the five autophosphorylation sites in the epidermal growth factor receptor. Plasmon resonance and immunological techniques were employed to measure interactions between SH2 fusion proteins and phosphotyrosine-containing peptides. The N-SH2 domain recognized peptides in the order of pY1173 > pY992 > pY1068 > pY1148 >> pY1086, while the C-SH2 domain recognized peptides in the order of pY992 > pY1068 > pY1148 >> pY1086 and pY1173. The major autophosphorylation site, pY1173, was recognized only by the N-SH2 domain. Contributions of the N-SH2 and C-SH2 domains to the association of the intact PLC-gamma1 molecule with the activated epidermal growth factor (EGF) receptor were assessed in vivo. Loss of function mutants of each SH2 domain were produced in a full-length epitope-tagged PLC-gamma1. After expression of the mutants, cells were treated with EGF and association of exogenous PLC-gamma1 with EGF receptors was measured. In this context the N-SH2 is the primary contributor to PLC-gamma1 association with the EGF receptor. The combined results suggest an association mechanism involving the N-SH2 domain and the pY1173 autophosphorylation site as a primary event and the C-SH2 domain and the pY992 autophosphorylation site as a secondary event.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10473558     DOI: 10.1074/jbc.274.37.26091

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

Review 1.  The ErbB signaling network: receptor heterodimerization in development and cancer.

Authors:  M A Olayioye; R M Neve; H A Lane; N E Hynes
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

Review 2.  ErbB-4: a receptor tyrosine kinase.

Authors:  W Zhou; G Carpenter
Journal:  Inflamm Res       Date:  2002-02       Impact factor: 4.575

3.  Pleiotropic contributions of phospholipase C-gamma1 (PLC-gamma1) to T-cell antigen receptor-mediated signaling: reconstitution studies of a PLC-gamma1-deficient Jurkat T-cell line.

Authors:  B J Irvin; B L Williams; A E Nilson; H O Maynor; R T Abraham
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

4.  AXL mediates resistance to PI3Kα inhibition by activating the EGFR/PKC/mTOR axis in head and neck and esophageal squamous cell carcinomas.

Authors:  Moshe Elkabets; Evangelos Pazarentzos; Dejan Juric; Qing Sheng; Raphael A Pelossof; Samuel Brook; Ana Oaknin Benzaken; Jordi Rodon; Natasha Morse; Jenny Jiacheng Yan; Manway Liu; Rita Das; Yan Chen; Angela Tam; Huiqin Wang; Jinsheng Liang; Joseph M Gurski; Darcy A Kerr; Rafael Rosell; Cristina Teixidó; Alan Huang; Ronald A Ghossein; Neal Rosen; Trever G Bivona; Maurizio Scaltriti; José Baselga
Journal:  Cancer Cell       Date:  2015-04-13       Impact factor: 31.743

5.  The ErbB4 receptor in fetal rat lung fibroblasts and epithelial type II cells.

Authors:  Washa Liu; Katja Zscheppang; Sandy Murray; Heber C Nielsen; Christiane E L Dammann
Journal:  Biochim Biophys Acta       Date:  2007-05-05

6.  Targeting PKCδ as a Therapeutic Strategy against Heterogeneous Mechanisms of EGFR Inhibitor Resistance in EGFR-Mutant Lung Cancer.

Authors:  Pei-Chih Lee; Yueh-Fu Fang; Hirohito Yamaguchi; Wei-Jan Wang; Tse-Ching Chen; Xuan Hong; Baozhen Ke; Weiya Xia; Yongkun Wei; Zhengyu Zha; Yan Wang; Han-Pin Kuo; Chih-Wei Wang; Chih-Yen Tu; Chia-Hung Chen; Wei-Chien Huang; Shu-Fen Chiang; Lei Nie; Junwei Hou; Chun-Te Chen; Longfei Huo; Wen-Hao Yang; Rong Deng; Katsuya Nakai; Yi-Hsin Hsu; Shih-Shin Chang; Tai-Jan Chiu; Jun Tang; Ran Zhang; Li Wang; Bingliang Fang; Ting Chen; Kwok-Kin Wong; Jennifer L Hsu; Mien-Chie Hung
Journal:  Cancer Cell       Date:  2018-12-10       Impact factor: 31.743

7.  Combined inhibition of PLC{gamma}-1 and c-Src abrogates epidermal growth factor receptor-mediated head and neck squamous cell carcinoma invasion.

Authors:  Hiroshi Nozawa; Gina Howell; Shinsuke Suzuki; Qing Zhang; Yanjun Qi; Judith Klein-Seetharaman; Alan Wells; Jennifer R Grandis; Sufi M Thomas
Journal:  Clin Cancer Res       Date:  2008-07-01       Impact factor: 12.531

8.  The selectivity of receptor tyrosine kinase signaling is controlled by a secondary SH2 domain binding site.

Authors:  Jae Hyun Bae; Erin Denise Lew; Satoru Yuzawa; Francisco Tomé; Irit Lax; Joseph Schlessinger
Journal:  Cell       Date:  2009-08-07       Impact factor: 41.582

9.  Structural basis for recognition of the T cell adaptor protein SLP-76 by the SH3 domain of phospholipase Cgamma1.

Authors:  Lu Deng; C Alejandro Velikovsky; Chittoor P Swaminathan; Sangwoo Cho; Roy A Mariuzza
Journal:  J Mol Biol       Date:  2005-09-09       Impact factor: 5.469

10.  Effect of lapatinib on the outgrowth of metastatic breast cancer cells to the brain.

Authors:  Brunilde Gril; Diane Palmieri; Julie L Bronder; Jeanne M Herring; Eleazar Vega-Valle; Lionel Feigenbaum; David J Liewehr; Seth M Steinberg; Maria J Merino; Stephen D Rubin; Patricia S Steeg
Journal:  J Natl Cancer Inst       Date:  2008-07-29       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.